Kardiolytics

Curated by Signal

Provider of AI-based image processing solution for coronary artery atherosclerotic stenosis

Life Sciences Technologykardiolytics.com

Overview

Provider of AI-based image processing solution for coronary artery atherosclerotic stenosis. The Virtual Cardiac Stress test is a non-invasive, personalized,3D modeling of coronary blood flow which helps in diagnosis and treatment for coronary artery disease.

Key facts

Founded: 2018
Headquarters: Chicago, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

1 product or service: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

PocketECG
Provider of non invasive mobile ECG and arrythmia diagnostic technology
Life Sciences TechnologyCosta Mesa, United States
Preventice Solutions
Provider of cloud-based remote telemonitoring platform for healthcare providers
Life Sciences TechnologyValley City, United States
Freenome
Provider of a deep learning platform for detecting circulating cancer-related markers
Life Sciences TechnologyUnited States

About Kardiolytics

What does Kardiolytics do?

Provider of AI-based image processing solution for coronary artery atherosclerotic stenosis.

Where is Kardiolytics headquartered?

Kardiolytics is headquartered in Chicago, United States.

When was Kardiolytics founded?

Kardiolytics was founded in 2018.

Which sector is Kardiolytics in?

Kardiolytics operates in Life Sciences Technology.

Who are Kardiolytics's competitors?

Companies similar to Kardiolytics include PocketECG, Preventice Solutions, and Freenome.